The Food and Drug Administration is working to prevent potential medical device shortages due to the closing of a Willowbrook, Ill., facility that sterilizes medical devices, the agency announced yesterday. Sterigenics processed nearly 600 types of medical devices at the facility, including products such as sutures, clamps, knives, stents and needles. “At this time, the FDA isn’t aware of any device shortages attributable to the Willowbrook facility closure,” said FDA Commissioner Scott Gottlieb, M.D. “We’re closely monitoring the situation and will continue to provide updates.” FDA also expects a sterilizing facility operated by Viant in Grand Rapids, Mich., to close later this year. The agency is encouraging medical device manufacturers to consider alternative contract sterilizers that can process their devices. Among other actions, FDA has established an email address for reporting anticipated device shortages or distribution delays at deviceshortages@fda.hhs.gov.

Related News Articles

Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
The Government Accountability Office Dec. 21 recommended the Food and Drug Administration and Cybersecurity and Infrastructure and Security Agency update a 5-…
Headline
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device…
Headline
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,…
Headline
The Food and Drug Administration the week of Aug. 7 cleared for marketing the first sterilization system for 3D-printed devices in health care facilities. The…
Headline
The Environmental Protection Agency today proposed requiring commercial sterilization facilities to comply within 18 months with stricter emission and…